Sign inJoin waitlistJoin the waitlist

Ian Frank

Associate Chief, Infectious Diseases Division · Penn Medicine

Credentials: · · · ·

History

Infectious Diseases Division · Penn Medicine
Present
Hospital of the University of Pennsylvania
Present
Penn Medicine
Present

Graduate Hospital
Dartmouth Medical School
1980

Research

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV
New England Journal of Medicine · 2014 · 1,038 citations
Topographical continuity of bacterial populations in the healthy human respiratory tract
American Journal of Respiratory and Critical Care Medicine · 2011 · 880 citations
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
Science · 2021 · 783 citations

Robert Gross
25 papers
Juliana McElrath
22 papers
Pablo Tebas
20 papers
Lawrence Corey
18 papers
Magdalena Sobieszczyk
14 papers
Michael Keefer
14 papers
DD
Debora Dunbar
13 papers
Karam Mounzer
13 papers
Lindsey Baden
13 papers
JK
Jay Kostman
11 papers
Harvey Friedman
10 papers
Jim Kublin
10 papers

Grants

University of Pennsylvania HIV Clinical Trials Unit
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $31.8M · University of Pennsylvania
2007–2027
Penn Center for AIDS Research
National Institute of Allergy and Infectious Diseases · P30
Project lead · $7.3M · University of Pennsylvania
1999–2024
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $4.7M · University of Pennsylvania
1997–2005
The Role of Neurtrophils in Vasculitis of Viral Etiology
National Heart, Lung, and Blood Institute · F32
Contact PI · $26.8K · University of Pennsylvania
1986

Clinical trials

Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccines, Given Individually or Co-administered, in Healthy, HIV-1-Uninfected Adults
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2018–2020
Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected Adults
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2011–2017
Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV
Study chair · Completed · Phase 1, Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2001–2006
The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2000